Letizia Traversi
Overview
Explore the profile of Letizia Traversi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
15
Citations
53
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Felipe Montiel A, Fernandez A, Amigo M, Traversi L, Clofent Alarcon D, Reyes K, et al.
Eur Respir Rev
. 2024 Oct;
33(174).
PMID: 39477350
The prognosis of people with cystic fibrosis (pwCF) has improved dramatically with the introduction of cystic fibrosis transmembrane conductance regulator (CFTR) modulators (CFTRm). The ageing of the cystic fibrosis (CF)...
2.
Traversi L, Garriga-Grimau L, Moreno-Galdo A, Polverino E
Arch Bronconeumol
. 2024 Oct;
PMID: 39426890
Paediatric and adult bronchiectasis patients have been addressed in the literature as two different populations due to several differences, but there is insufficient evidence to understand how and when disease...
3.
Nigro M, Laska I, Traversi L, Simonetta E, Polverino E
Eur Respir Rev
. 2024 Oct;
33(174).
PMID: 39384303
Bronchiectasis is a chronic respiratory disease characterised by permanent enlargement of the airways associated with cough, sputum production and a history of pulmonary exacerbations. In the past few years, incidence...
4.
Polverino E, Dimakou K, Traversi L, Bossios A, Haworth C, Loebinger M, et al.
J Allergy Clin Immunol
. 2024 Feb;
153(6):1553-1562.
PMID: 38401857
Background: Asthma is commonly reported in patients with a diagnosis of bronchiectasis. Objective: The aim of this study was to evaluate whether patients with bronchiectasis and asthma (BE+A) had a...
5.
Felipe Montiel A, Fernandez A, Traversi L, Polverino E
Expert Rev Respir Med
. 2024 Feb;
17(12):1091-1094.
PMID: 38347811
No abstract available.
6.
Polverino E, Soyza A, Dimakou K, Traversi L, Bossios A, Crichton M, et al.
Am J Respir Crit Care Med
. 2024 Jan;
210(1):119-127.
PMID: 38271696
COPD and bronchiectasis are commonly reported together. Studies report varying impacts of co-diagnosis on outcomes, which may be related to different definitions of disease used across studies. To investigate the...
7.
Tur-Torres J, Traversi L, Martinez-Gallo M, Assante G, Romero Mesones C, Clofent Alarcon D, et al.
Arch Bronconeumol
. 2022 Jun;
57(11):708-710.
PMID: 35699016
No abstract available.
8.
Traversi L, Miravitlles M, Martinez-Garcia M, Shteinberg M, Bossios A, Dimakou K, et al.
ERJ Open Res
. 2021 Nov;
7(4).
PMID: 34820447
Introduction: The coexistence of COPD and bronchiectasis seems to be common and associated with a worse prognosis than for either disease individually. However, no definition of this association exists to...
9.
Clofent D, Alvarez A, Traversi L, Culebras M, Loor K, Polverino E
Expert Rev Respir Med
. 2021 Feb;
15(5):623-634.
PMID: 33583300
: Comorbidities in patients with bronchiectasis are common and have a significant impact on clinical outcomes, contributing to lower quality of life, lung function, and exacerbation frequency. At least 13...
10.
Tur-Torres J, Traversi L, Martinez-Gallo M, Assante G, Romero Mesones C, Clofent Alarcon D, et al.
Arch Bronconeumol (Engl Ed)
. 2020 Dec;
PMID: 33328136
No abstract available.